The connection of the sugars part to C-3 of
the aglycone was confirmed by the correlation
of an anomeric proton (δH 4.54) and C-3
position (δC 79.1) in the HMBC spectrum. This
carbohydrate consisted of one disubstituted
glucose and two terminal rhamnose moieties.
The linkage positions of the sugars were
determined by HMBC spectrum. Accordingly,
the anomeric proton signal observed in 1H-NMR
spectrum at δH 5.00 correlated with C-2 (δC
79.4) of glucose, the anomeric proton signal
observed in 1H-NMR spectrum at δH 4.92
correlated with C-3 (δ 88.3) of glucose.
Furthermore, the presence of two upfield signals
of methyl protons at δ 1.26 (d, J = 1.5 Hz), and
1.28 (d, J = 1.5 Hz) in its 1H-NMR spectrum
confirmed that the two deoxyhexopyranose
units were rhamnose moieties. The
rhamnopyranosyl residues were shown to be
terminal units as suggested by the absence of
any glysosydation shift for their carbon
resonances. The 2,3 distribution of the
glucopyranosyl moiety was shown by downfield
chemical shifts at δ 79.4 (C-2 GlcI) and 88.3 (C-
3 GlcI) in the 13C-NMR spectrum. The NMR
data were in good agreement with literature data
(Tepono, 2001; Yokosuka, 2002).
The remaining sugar moiety was also
determined by extensive spectroscopic studies.
The strong downfield shift signal at C-24 (δ
82.0) in 13C-NMR spectrum was indicative of
the presence of one sugar moiety at this
position. The correlation observed in HMBC
spectrum between the anomeric proton (δH 4.37
(d, J = 7.5 Hz)) and C-24 (δC 82.0) confirmed
that one glucose unit connected to C-24 of the
F-ring. By above evidence and comparison with
published data (Mimaki, 2001), 1 was identified
as 24-O-β-D-glucopyranosyl-3-O-α-L-rhamnopyranosyl-(1→2)-[α-L-rhamnopysanosyl-
(1→3)]-β-D-glucopyranosylpennogenin which
were named as dracagenin A. This is the first
report of this compound from the nature.
Compound 2 was obtained as white powder.
Inspecting the NMR data of 2 revealed that 2
was a spirostane-type sterol. The NMR data of 2
were similar to those of the aglycone of 1 except
for the appearance of two hydroxyl group at C-1
(δH 3.46 (dd, J = 4.0, 11.5 Hz)/ δC 77.7) and C-
14 (δC 87.6) and the upfield shifts of the signals
of F-ring from C-23 to C-27. This evidence
suggested to the 25S configuration of 2. The
13C-NMR spectrum of 2 showed the upfield
507shift of the oxygenated signal (δ 58.8) assigned
to C-17 in 1. Therefore, C-17 was considered as
a methine group. The spectroscopic data of 2
were compared with those of 25S-namogenin B
and found to match (Tran, 2001). By carried out
the same methods on structure elucidation using
spectroscopic evidence, compound 3 were
determine to be spriroconazole A, which were
isolated from D. manii, D. arborea, and
Dioscorea bulbifera L.var sativa (Tepono,
2001).
The isolated compounds were evaluated for
their antifungal activities. 1 and 3 exhibited
inhibitory activity against Aspergilus niger at
the MICs of 50 μg/ml. No inhibition effects on
F. oxysporum, S. cerevisiae and C. albicans
have been found for the tested compounds. 2
was inactive against all tested fungi.
Interestingly, toxicity of 3 towards several
cancer cell lines has been demonstrated. The
IC50 of 3 against Hep-2, Lu, and RD are 2.002,
4.727, and 4.029 μg/ml, respectively. Thus, 1
and 3 should be considered to be promising
antifungal agents from D. cambodiana.
6 trang |
Chia sẻ: honghp95 | Lượt xem: 481 | Lượt tải: 0
Bạn đang xem nội dung tài liệu Antifungal constituents from the stems of dracaena cambodiana - Nguyen Hai Dang, để tải tài liệu về máy bạn click vào nút DOWNLOAD ở trên
Journal of Chemistry, Vol. 46 (4), P. 503 - 508, 2008
ANTIFUNGAL CONSTITUENTS FROM THE STEMS OF
DRACAENA CAMBODIANA
Received 6 September 2007, Revised 1 November 2007
Nguyen Hai Dang1, Phan Van Kiem1, Chau Van Minh1, and Tran Thu Huong2
Institute of Natural Products Chemistry, Vietnamese Academy of Science and Technology
1Faculty of Chemical Technology, Hanoi University of Technology, summary
summary
The stems of Dracaena cambodiana have been investigated for antifungal constituents,
resulting in the isolation of a new steroidal saponin dracagenin A (1) together with two known
components 25S-namogenin B (2) and spriroconazole A (3). Their structures were elucidated on
the basis of extensive spectroscopic analysis including 1D, 2D NMR and ESI MS. The isolated
compounds were evaluated for their antifungal activities. 1 and 3 exhibited inhibitory activity
against Aspergilus niger at the MICs of 50 μg/ml. No inhibition effects on F. oxysporum, S.
cerevisiae and C. albicans have been found for the tested compounds. Interestingly, toxicity of 3
towards several cancer cell lines has been demonstrated. The IC50 of 3 against Hep-2, Lu, and RD
are 2.002, 4.727, and 4.029 μg/ml, respectively.
Keywords: Dracaenaceae, Dracaena cambodiana, Steroidal saponin, Dracagenin A.
I - INTRODUCTION
Dracaena cambodiana (Dracaenaceae) is
mostly distributed in the North of Vietnam. The
plant has been found in ethnomedicine to treat
menoschesis, ostealgia etc (Bich, 2006; Chi,
1997; Loi, 2001). Investigations on the chemical
constituents of the genus revealed that the
spirosterol and steroidal saponin are among the
major components (Gonzalez, 2004; Mimaki,
1998). Interestingly, there has been no report on
the phytochemical of D. cambodiana. On our
continuing studies for antifungal agents, we
have isolated a new steroidal saponin namely
dracagenin A (1), one sprirosterol 25S-
namogenin B (2) and one known steroidal
saponin spriroconazole A (3). The antifungal
activities of these compounds were also
described.
II - MATERIALS AND METHODS
General experiment procedures
The 1H-NMR (500 MHz) and 13C-NMR
(125 MHz) spectra were recorded on a Bruker
AM500 FT-NMR spectrometer. Chemical shifts
are referenced to δ using tetramethylsilan
(TMS) as an internal standard. The Electron
Spray Ionization (ESI) mass spectrum was
obtained using an AGILENT 1100 LC-MSD
Trap spectrometer. Column chromatography
(CC) was performed on silicagel 230 - 400 mesh
(0.040-0.063 mm, Merck) or YMC RP-18 resins
(30-50 μm, FuJisilisa Chemical Ltd.). Thin layer
chromatography (TLC) was performed on DC-
Alufolien 60 F254 (Merck 1.05715) or RP18 F254s
(Merck) plates.
Plant material
The roots of D. cambodiana were collected
in Hoabinh province, Vietnam in January 2006
503
and identified by Dr. Tran Huy Thai, Institute of
Ecology and Biological Resources, VAST,
Vietnam. An authentic sample was deposited at
the Institute of Natural Products Chemistry,
VAST, Vietnam.
Extraction and isolation
The dried roots of D. cambodiana (4 kg)
were extracted with MeOH three times (7 days
each time) and then concentrated under low
pressure to obtain 150 g MeOH extract. The
MeOH extract was suspended in water and
partitioned with hexane, CHCl3 and BuOH to
obtain n-hexane (60 g), CHCl3 (35 g), and
BuOH (65 g) fractions. The CHCl3 fraction was
then chromatographed on silicagel column
eluting with CHCl3-MeOH gradient (from 10:1
to 1:1 v/v) to give fractions C1 (16 g), C2 (11 g),
and C3 (7 g). C1 fraction was chromatographed
on a silicagel column using CHCl3-EtOAc (3:1)
as eluent to give subfractions C3A (6.5 g), C3B
(3.4 g), C3C (6.0 g). The C3C subfraction (6.0
g) was chromatographed on a silica gel column
using a CHCl3-MeOH (3:1 v/v) system as eluent
yielded 2 (25 mg) as white powder. The BuOH
fraction was chromatographed on silicagel
column eluting with CHCl3-MeOH gradient
(from 10:1 to 1:1 v/v) to obtain fractions B1 (25
g), B2 (20 g), and B3 (12 g). B2 fraction showed
the most active antifungal activity then selected
for further isolation of bioactive compounds.
The B2 fraction (20 g) was chromatographed on
an YMC RP-18 column using a MeOH-H2O
(2:1 v/v) system as eluent yielded 1 (18.5 mg)
and 3 (9 mg) as white amorphous powder.
25S-Namogenin B (2): White powder,
positive ESI-MS m/z: 447 [M+H]+, 429 [M+H-
H2O]
+, 411 [M+H-2H2O]
+; negative ESI-MS
m/z: 445 [M-H]-; 1H-NMR (500 MHz, CDCl3) δ:
3.46 (dd, J = 4.0, 11.5 Hz, H-1), 1.57/2.06 (m,
H-2), 3.53 (m, H-3), 1.89/2.24 (m, H-4), 5.57
(d, J = 5.5 Hz, H-6), 1.94/2.08 (m, H-7), 1.97
(m, H-8), 1.59 (m, H-9), 1.60/2.11 (m, H-11),
1.42/1.75 (m, H-12), 1.61/1.95 (m, H-15), 4.60
(m, H-16), 2.29 (m, H-17), 0.94 (s, H-18), 1.07
(s, H-19), 2.10 (m, H-20), 1.01 (d, J = 7.0 Hz,
H-21), 1.94/2.02 (m, H-23), 1.40/2.11 (m, H-
24), 1.72 (m, H-25), 3.29 (d, J =2.5 Hz, H-26a),
3.93 (d, J = 11.0 Hz, H-26b), 0.90 (d, J = 7.0
Hz, H-27); 13C-NMR (125 MHz, CDCl3) δ: 77.7
(C-1), 42.0 (C-2), 67.9 (C-3), 42.6 (C-4), 137.6
(C-5), 125.5 (C-6), 26.2 (C-7), 35.7 (C-8), 43.7
(C-9), 43.2 (C-10), 22.6 (C-11), 32.0 (C-12),
44.0 (C-13), 87.6 (C-14), 39.4 (C-15), 81.9 (C-
16), 58.8 (C-17), 20.0 (C-18), 13.0 (C-19), 42.2
(C-20), 14.5 (C-21), 110.0 (C-22), 26.1 (C-23),
25.8 (C-24), 27.1 (C-25), 65.1 (C-26), 16.1 (C-
27).
Spriroconazole A (3): White powder,
positive ESI-MS m/z: 907 [M+Na]+; negative
ESI-MS m/z: 883 [M-H]-; 1H-NMR (500 MHz,
CDCl3) δ: 1.11/1.90 (m, H-1), 1.31/1.91 (m, H-
2), 3.66 (m, H-3), 2.29/2.47 (m, H-4), 5.40 (d, J
= 5.0 Hz, H-6), 1.37/1.59 (m, H-7), 1.65 (m, H-
8), 0.98 (m, H-9), 1.54/1.63 (m, H-11),
1.65/2.03 (m, H-12), 1.73 (m, H-14), 1.25/1.71
(m, H-15), 4.01 (dd, J = 7.0, 8.0 Hz, H-16),
0.85 (s, H-18), 1.07 (s, H-19), 2.11 (m, H-20),
0.94 (d, J = 7.0 Hz, H-21), 1.70/2.03 (m, H-23),
1.45/1.62 (m, H-24), 1.62 (m, H-25), 3.36/3.47
(m, H-26), 0.81 (d, J = 6.5 Hz, H-27), 4.53 (d,
J = 7.0 Hz, H-1Glc), 3.58 (t, J = 9.0 Hz, H-3
Glc), 4.99 (d, J = 1.5 Hz, H-1 RhaI), 1.26 (d, J
= 6.5 Hz, H-6 RhaI), 4.92 (d, J = 1.5 Hz, H-1
RhaII), 1.28 (d, J = 6.5 Hz, H-6 RhaII); 13C-
NMR (125 MHz, CDCl3) δ: 38.6 (C-1), 30.8 (C-
2), 79.1 (C-3), 39.3 (C-4), 141.9 (C-5), 122.9
(C-6), 32.8 (C-7), 33.3 (C-8), 51.5 (C-9), 38.0
(C-10), 21.7 (C-11), 33.2 (C-12), 45.8 (C-13),
53.1 (C-14), 32.1 (C-15), 90.6 (C-16), 91.3 (C-
17), 17.5 (C-18), 19.8 (C-19), 45.5 (C-20), 9.1
(C-21), 111.0 (C-22), 32.5 (C-23), 29.4 (C-24),
31.3 (C-25), 67.7 (C-26), 17.5 (C-27), Glc (1)
100.2, (2) 97.4, (3) 88.4, (4) 70.5, (5) 77.5, (6)
62.6, RhaI (1) 102.8, (2) 72.3, (3) 72.5, (4)
73.6, (5) 70.1, (6) 17.8, RhaII (1) 103.9, (2)
72.2, (3) 72.4, (4) 73.8, (5) 70.9, (6) 18.1.
III - RESULTS AND DISCUSSION
Bioassay guided fractionation led to the
isolation of three bioactive components.
Compound 1 was obtained as white amorphous
powder, The ESI MS (positive mode) showed
the pseudomolecular [M+Na]+ ion peak at m/z
1085 (corresponding to the molecular formula
C51H82O23). The
13C-NMR spectrum of 1 showed
504
OOHO
O
O
O
OH
HO
OH
HO
OHOO
O
OH
O
OH
OH
OH
CH3O
OH
HO
HO
H3C
RhaIRhaII
1
2
3
4
5
6
7
8
9
10
11
12
13
14 15 16
17
18
19
20
21
22 23 24
2526
27
GlcI
GlcII
1
O
O
HO
1
2
3
4
5
6
7
8
9
10
11
12
13
14 15 16
17
18
19
20
21
22 23 24
2526
27
OH
OH
2
O
OHO
O
OHOO
O
OH
O
OH
OH
OH
CH3O
OH
HO
HO
H3C
RhaIRhaII
1
2
3
4
5
6
7
8
9
10
11
12
13
14 15 16
17
18
19
20
21
22 23 24
2526
27
GlcI
3
Figure 1: Structures of 1-3
51 signals, among which 27 were assigned to
the aglycone, the remaining 24 signals were
indicative of the presence of four hexoses due to
two D-glucoses and two L-rhamnoses. The
structure of the aglycone moiety was recognized
to be penogenin (3β,17α-dihydroxyspirost-5en)
by 1H- and 13C-NMR spectral analysis using
connectivities observed in COSY, HSQC, and
505
HMBC. The 1H-NMR spectrum of 1 showed
two three-proton singlet signals at δ 0.83 and
1.07 and two three-proton doublet signals at δ
0.91 (J = 7.5 Hz) and 1.00 (J = 6.5 Hz), which
were characteristic of the spirostanol skeleton,
as well as signals for four anomeric protons at δ
4.54 (d, J =7.5 Hz), 4.37 (d, J = 7.5 Hz), 5.00
(d, J = 1.5 Hz), 1.92 (d, J = 1.5 Hz). The salient
features of this aglycone part were the 13C-NMR
signals at δ 141.9 (C-5) and 122.6 (C-6),
characteristic of Δ5-spirostene-type sapogenin.
The proton coupling constant between H-25 and
H-26ax (J = 11.5 Hz), and the
13C-NMR shifts of
the F-ring part (C-25/δ 38.5) gave an evidence
for the C-25R configuration.
Table 1: NMR data of 1
No. δCa,b δHa,c (J, Hz) HMBC (H to C)
1 38.6 1.13 m; 1.90 m C-5
2 30.7 1.62 m; 1.91 m
3 79.1 3.65 m C-1 Glc
4 39.3 2.30 m; 2.47 m C-2, C-5, C-6, C-10
5 141.9
6 122.6 5.40 d (5.5) C-8, C-10
7 32.8 1.37 m; 1.68 m
8 33.3 1.65 m
9 51.5 0.97 m
10 38.0
11 21.7 1.49 m; 1.63 m
12 33.2 1.59 m; 2.03 m
13 45.7
14 53.9 1.74 m
15 32.0 1.31 m; 2.05 m C-15, C-17
16 90.9 3.99 t (6.5)
17 91.8
18 17.5 0.83 s C-12, C-13, C-14, C-17
19 19.8 1.07 s C-4, C-9
20 45.9 2.16 m C-14, C-17, C-21, C-23
21 9.0 0.91 d (7.5) C-17, C-20, C-22
22 113.8
23 41.0 1.69 m; 2.22 m C-24, C-25
24 82.0 3.62 m
25 38.5 1.67 m
26 65.8 3.38 m; 3.53 m C-24, C-27
27 13.5 1.00 d (6.5) C-24, C-26
GlcI (1 → C3)
1 100.2 4.54 d (7.5) C-3
2 79.4 3.47 m
3 88.4 3.60 m C-2 Glc, C-4, Glc
4 70.6 3.40 m
5 77.5 3.29 m
6 62.6 3.70 m; 3.88 m
RhaI (1 → 2Glc)
1 102.8 5.00 d (1.5) C-2 Glc, C-3 Rha, C-5 Rha
2 72.3 3.64 m
506
No. δCa,b δH
a,c (J, Hz) HMBC (H to C)
3 72.5 3.88 m
4 73.6 3.43 m
5 70.1 4.10 m
6 17.8 1.26 d (6.0)
RhaII (1 → 3Glc)
1 103.9 4.92 d (1.5) C-3 Glc, C-3 Rha’, C-5 Rha’
2 72.2 3.86 m
3 72.4 3.66 m
4 73.8 3.43 m
5 70.9 3.95 m
6 18.1 1.28 d (6.0)
GlcII (1 → C24)
1 106.0 4.37 d (7.5) C-24
2 75.5 3.17 m
3 78.1 3.39 m
4 71.7 3.33 m C-5 Glc’
5 77.7 3.31 m
6 62.8 3.70 m; 3.88 m
aMeasured in CD3OD,
b125 MHz, c500 MHz, Chemical shift (δ) in ppm.
The connection of the sugars part to C-3 of
the aglycone was confirmed by the correlation
of an anomeric proton (δH 4.54) and C-3
position (δC 79.1) in the HMBC spectrum. This
carbohydrate consisted of one disubstituted
glucose and two terminal rhamnose moieties.
The linkage positions of the sugars were
determined by HMBC spectrum. Accordingly,
the anomeric proton signal observed in 1H-NMR
spectrum at δH 5.00 correlated with C-2 (δC
79.4) of glucose, the anomeric proton signal
observed in 1H-NMR spectrum at δH 4.92
correlated with C-3 (δ 88.3) of glucose.
Furthermore, the presence of two upfield signals
of methyl protons at δ 1.26 (d, J = 1.5 Hz), and
1.28 (d, J = 1.5 Hz) in its 1H-NMR spectrum
confirmed that the two deoxyhexopyranose
units were rhamnose moieties. The
rhamnopyranosyl residues were shown to be
terminal units as suggested by the absence of
any glysosydation shift for their carbon
resonances. The 2,3 distribution of the
glucopyranosyl moiety was shown by downfield
chemical shifts at δ 79.4 (C-2 GlcI) and 88.3 (C-
3 GlcI) in the 13C-NMR spectrum. The NMR
data were in good agreement with literature data
(Tepono, 2001; Yokosuka, 2002).
The remaining sugar moiety was also
determined by extensive spectroscopic studies.
The strong downfield shift signal at C-24 (δ
82.0) in 13C-NMR spectrum was indicative of
the presence of one sugar moiety at this
position. The correlation observed in HMBC
spectrum between the anomeric proton (δH 4.37
(d, J = 7.5 Hz)) and C-24 (δC 82.0) confirmed
that one glucose unit connected to C-24 of the
F-ring. By above evidence and comparison with
published data (Mimaki, 2001), 1 was identified
as 24-O-β-D-glucopyranosyl-3-O-α-L-rhamno-
pyranosyl-(1→2)-[α-L-rhamnopysanosyl-
(1→3)]-β-D-glucopyranosylpennogenin which
were named as dracagenin A. This is the first
report of this compound from the nature.
Compound 2 was obtained as white powder.
Inspecting the NMR data of 2 revealed that 2
was a spirostane-type sterol. The NMR data of 2
were similar to those of the aglycone of 1 except
for the appearance of two hydroxyl group at C-1
(δH 3.46 (dd, J = 4.0, 11.5 Hz)/ δC 77.7) and C-
14 (δC 87.6) and the upfield shifts of the signals
of F-ring from C-23 to C-27. This evidence
suggested to the 25S configuration of 2. The
13C-NMR spectrum of 2 showed the upfield
507
shift of the oxygenated signal (δ 58.8) assigned
to C-17 in 1. Therefore, C-17 was considered as
a methine group. The spectroscopic data of 2
were compared with those of 25S-namogenin B
and found to match (Tran, 2001). By carried out
the same methods on structure elucidation using
spectroscopic evidence, compound 3 were
determine to be spriroconazole A, which were
isolated from D. manii, D. arborea, and
Dioscorea bulbifera L.var sativa (Tepono,
2001).
The isolated compounds were evaluated for
their antifungal activities. 1 and 3 exhibited
inhibitory activity against Aspergilus niger at
the MICs of 50 μg/ml. No inhibition effects on
F. oxysporum, S. cerevisiae and C. albicans
have been found for the tested compounds. 2
was inactive against all tested fungi.
Interestingly, toxicity of 3 towards several
cancer cell lines has been demonstrated. The
IC50 of 3 against Hep-2, Lu, and RD are 2.002,
4.727, and 4.029 μg/ml, respectively. Thus, 1
and 3 should be considered to be promising
antifungal agents from D. cambodiana.
REFERENCES
1. D. H. Bich, D. Q. Chung, B. X Chuong, N.
T. Dong, D. T. Dam, P. V. Hien, V. N. Lo,
P. D. Mai, P. K. Man, D. T. Nhu, N. Tap, T.
Toan. Medicinal Animals and Plants in
Vietnam, Hanoi Science and Technology
Publishing House, Vol. 1 (2006).
2. V. V. Chi, V. V. (ed.). Vietnamese Medical
Plant Dictionary. Hanoi Medicinal
Publishing House (1997).
3. A. G. Gonzalez, F. Leon, J. C. Hernandez,
J. I. Padron, L. S. Pinto, J. B. Barrera.
Biochem. Syst. Ecol., 32, 179 - 184 (2004).
4. D. T. Loi (ed.). Glossary of Vietnamese
Medicinal Plants. Hanoi Science and
Technology Publishing House (2006).
5. Y. Mimaki, M. Koruda, Y. Takaashi, Y.
Sashida. Phytochemistry, 47, 1351 - 1356
(1998).
6. Y. Mimaki, K. Watanabe, H. Sakagami, Y.
Sashida. J. Nat. Prod., 64, 1127 - 1132
(2001).
7. R. B. Tepono, A. L. Tapondjou, J. D.
Djoukeng, E. Abou-Mansour, R. Tabacci, P.
Tane, D. Lontsi, H. J. Park. Nat. Prod. Sci.,
12, 62 - 66 (2006).
8. Q. L. Tran, Y. Tezuka, A. H. Banskota, Q.
K. Tran, I. Saiki, S. Kadota. J. Nat. Prod.,
64, 1127 - 1132 (2001).
9. A. Yokosuka, Y. Mimaki, Y. Sashida.
Phytochemistry, 61, 73 - 78 (2002).
508
Các file đính kèm theo tài liệu này:
- 4466_15941_1_pb_413_2085796.pdf